Among patients with atrial high-rate episodes detected by implantable devices, anticoagulation with edoxaban did not show a benefit but did increase bleeding risk in the NOAH-AFNET 6 trial.
A 2023 update of the Beers Criteria was released in May 2023 after panel review of more 1500 clinical trials and research studies published since the last update.
The growing awareness in health care of the challenges associated with proper dosing of anticoagulants such as heparin has inspired the emerging field of anticoagulation stewardship.
Although urate-lowering drugs form the cornerstone of gout therapy, there are only three oral medications currently available in the United States, and all have significant limitations.
Left atrial appendage occlusion was associated with fewer injuries and less bleeding from falls in patients with atrial fibrillation and previous stroke, compared with oral anticoagulation.